blue cross glp 1 Independence to stop covering GLP-1 agonists Wegovy, Ozempic as weight loss drugs in 2025 Does Blue Cross Blue Shield

In several reported cases, symptoms improved following medication discontinuation, suggesting a potential causal relationship

Menzaghi C, et al

doi: 10.3390/cimb45060288 58 BudakMachnikGBudakRJabuzekKBodysABelowskiDet al

Body composition is one of the best indicators of overall health, linked to risks for cardiovascular disease, diabetes, osteoporosis, and more

It prioritizes lifestyle changes, nutritional advice, and continuous assistance

Together, these findings underscore the clinical relevance of thyroidECM interactions in MAFLD and support the development of precision therapies for patients with comorbid thyroid dysfunction and liver fibrosis